ANDA 78623, held by Apotex Inc. Albuterol Sulfate.
As of Nov 16, 2026, ANDA 78623 (Albuterol Sulfate), held by Apotex Inc, was first approved by FDA on Apr 5, 2010, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 5, 2010 | Original application | Approved | None posted |
| Albuterol SulfateEQ 0.021% BASE · solution;inhalation | Albuterol Sulfate | Discontinued |
| Albuterol SulfateEQ 0.042% BASE · solution;inhalation | Albuterol Sulfate | Discontinued |
| Feb 2, 2023 | Supplement 2Labeling · Standard review | Approved | None posted |
| Feb 28, 2014 | Supplement 1Labeling · Standard review | Approved | None posted |
| Apr 5, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters